Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.
회사 코드ALUR_t
회사 이름Allurion Technologies Inc
상장일Mar 29, 2021
설립일2023
CEODr. Shantanu Gaur, M.D.
직원 수- -
유형- -
회계 연도 종료- -
주소11 Huron Dr Ste 200
도시NATICK
증권 거래소- -
국가United States of America
우편 번호01760
전화15086474000
웹사이트https://www.allurion.com/en
회사 코드ALUR_t
상장일Mar 29, 2021
설립일2023
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음